Cyclosporin in the management of polymyositis and dermatomyositis.
Three patients with polymyositis refractory to conventional steroid and immunosuppressive treatment, but responsive to cyclosporin A, are described. In a fourth patient cyclosporin A was used as a first line drug in combination with steroids in the treatment of life-threatening dermatomyositis. Cyclosporin A in the management of polymyositis/dermatomyositis requires formal assessment of its costs and benefits compared with conventional treatments.
Lueck
C J
CJ
Department of Neurology, Royal London Hospital, UK.
Trend
P
P
Swash
M
M
D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use*; D003882:Dermatomyositis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009220:Myositis / Q000188:drug therapy*
D016572:Cyclosporine